Clinical Trial to Evaluate ANT-1401 in Crow's Feet

Completed · Phase 2

Conditions studied: Lateral Canthal Lines, Crows Feet

In brief

The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.

Key facts

Study ID

NCT01809964

Run by

Anterios Inc.

People needed

109

Starts

2013-03-01

Expected to finish

2013-10-01

Last updated by the study team

2014-01-10

Who can join

Age: 30 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 30 - 60 years of age
• mild to moderate Crow's Feet wrinkles (IGA 1-2) at rest
• moderate to severe Crow's Feet (IGA 2-3) on contraction
• moderate to severe Crow's Feet (SSA 2-3) on contraction
• Have adequate vision to assess facial wrinkles in a mirror

You may not qualify if…

• botulinum toxin treatment in the prior 6 months
• history of periocular surgery, brow lift or related procedures
• soft tissue augmentation in the lateral canthal region in the prior 12 months
• dermabrasion or laser treatment in the periocular region in the last 6 months
• topical prescription-strength retinoids in the prior 3 months
• present or history of neuromuscular disease
• present or history of "dry eye"
• systemic aminoglycoside use in the week prior to treatment application

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Miami, Florida, United States
• Study site — Pinellas Park, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Louisville, Kentucky, United States
• Study site — Metairie, Louisiana, United States
• Study site — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.